Pulse Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. (PLSE) on December 19, 2019, reporting an event that occurred on December 17, 2019. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director:
- Thomas J. Fogarty, M.D. resigned from the Board of Directors and all Board committees effective immediately on December 17, 2019.
- The resignation was for personal reasons.
- The Company stated the resignation is not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors beyond the standard disclosure regarding the director's departure.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors following Dr. Fogarty's resignation.
- Confirm if the Company intends to appoint a replacement director and the timeline for such an appointment.
- Review subsequent filings for any impact on the Company's strategic direction or committee structures.